CVS Health Corporation
CVS
65.22
USD-0.23
(-0.35%)Day's range
64.91
66.42
52 wk Range
43.56
71.45
Key ratios
Statements Highlights
| Period Ending | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
|---|---|---|---|---|---|---|
| Total Revenue | 268,706,000,000 | 292,111,000,000 | 322,467,000,000 | 357,776,000,000 | 372,809,000,000 | |
| Gross Profit | 49,046,000,000 | 52,120,000,000 | 54,502,000,000 | 54,431,000,000 | 51,401,000,000 | |
| Operating Income | 13,911,000,000 | 13,310,000,000 | 7,954,000,000 | 13,743,000,000 | 8,516,000,000 | |
| Net Income | 7,179,000,000 | 8,001,000,000 | 4,311,000,000 | 8,344,000,000 | 4,614,000,000 | |
| Total Assets | 230,715,000,000 | 232,999,000,000 | 228,275,000,000 | 249,728,000,000 | 253,215,000,000 | |
| Total Current Liabilities | 62,017,000,000 | 67,807,000,000 | 69,421,000,000 | 79,189,000,000 | 84,609,000,000 | |
| Total Equity | 69,701,000,000 | 75,381,000,000 | 71,769,000,000 | 76,636,000,000 | 75,730,000,000 | |
| Free Cash Flow | 13,428,000,000 | 15,745,000,000 | 13,450,000,000 | 10,395,000,000 | 6,326,000,000 | |
| Cash from Operations | 15,865,000,000 | 18,265,000,000 | 16,177,000,000 | 13,426,000,000 | 9,107,000,000 | |
| Cash from Investing | -5,534,000,000 | -5,261,000,000 | -5,047,000,000 | -20,889,000,000 | -7,613,000,000 | |
| Cash from Financing | -7,696,000,000 | -11,356,000,000 | -10,516,000,000 | 2,683,000,000 | -1,135,000,000 | |
| Net Change in Cash | 2,635,000,000 | 1,648,000,000 | 614,000,000 | -4,780,000,000 | 359,000,000 |
Dividends
Analyst Recomendations
Overall consensus
Buy